NEO
Price
$8.19
Change
-$0.62 (-7.04%)
Updated
Sep 3 closing price
Capitalization
1.06B
68 days until earnings call
NEPH
Price
$4.15
Change
-$0.05 (-1.19%)
Updated
Sep 3 closing price
Capitalization
43.99M
63 days until earnings call
Interact to see
Advertisement

NEO vs NEPH

Header iconNEO vs NEPH Comparison
Open Charts NEO vs NEPHBanner chart's image
NeoGenomics
Price$8.19
Change-$0.62 (-7.04%)
Volume$3.43M
Capitalization1.06B
Nephros
Price$4.15
Change-$0.05 (-1.19%)
Volume$137.85K
Capitalization43.99M
NEO vs NEPH Comparison Chart in %
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. NEPH commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Buy and NEPH is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (NEO: $8.19 vs. NEPH: $4.15)
Brand notoriety: NEO and NEPH are both not notable
NEO represents the Medical Specialties, while NEPH is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: NEO: 137% vs. NEPH: 322%
Market capitalization -- NEO: $1.06B vs. NEPH: $43.99M
NEO [@Medical Specialties] is valued at $1.06B. NEPH’s [@Pharmaceuticals: Other] market capitalization is $43.99M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.15B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.59B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileNEPH’s FA Score has 0 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • NEPH’s FA Score: 0 green, 5 red.
According to our system of comparison, NEPH is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 6 TA indicator(s) are bullish while NEPH’s TA Score has 6 bullish TA indicator(s).

  • NEO’s TA Score: 6 bullish, 4 bearish.
  • NEPH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both NEO and NEPH are a good buy in the short-term.

Price Growth

NEO (@Medical Specialties) experienced а +15.68% price change this week, while NEPH (@Pharmaceuticals: Other) price change was +2.47% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.74%. For the same industry, the average monthly price growth was +8.47%, and the average quarterly price growth was +10.21%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.09%. For the same industry, the average monthly price growth was +6.96%, and the average quarterly price growth was +33.57%.

Reported Earning Dates

NEO is expected to report earnings on Nov 11, 2025.

NEPH is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+0.74% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-2.09% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEO($1.06B) has a higher market cap than NEPH($44M). NEPH YTD gains are higher at: 182.313 vs. NEO (-50.303). NEPH has higher annual earnings (EBITDA): 1.49M vs. NEO (-28.47M). NEO has more cash in the bank: 164M vs. NEPH (5.07M). NEPH has less debt than NEO: NEPH (1.24M) vs NEO (412M). NEO has higher revenues than NEPH: NEO (689M) vs NEPH (16.7M).
NEONEPHNEO / NEPH
Capitalization1.06B44M2,405%
EBITDA-28.47M1.49M-1,905%
Gain YTD-50.303182.313-28%
P/E RatioN/A34.58-
Revenue689M16.7M4,126%
Total Cash164M5.07M3,232%
Total Debt412M1.24M33,199%
FUNDAMENTALS RATINGS
NEO vs NEPH: Fundamental Ratings
NEO
NEPH
OUTLOOK RATING
1..100
2681
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9554
PRICE GROWTH RATING
1..100
4036
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5023

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (64) in the Medical Or Nursing Services industry is in the same range as NEPH (66) in the null industry. This means that NEO’s stock grew similarly to NEPH’s over the last 12 months.

NEO's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as NEPH (100) in the null industry. This means that NEO’s stock grew similarly to NEPH’s over the last 12 months.

NEPH's SMR Rating (54) in the null industry is somewhat better than the same rating for NEO (95) in the Medical Or Nursing Services industry. This means that NEPH’s stock grew somewhat faster than NEO’s over the last 12 months.

NEPH's Price Growth Rating (36) in the null industry is in the same range as NEO (40) in the Medical Or Nursing Services industry. This means that NEPH’s stock grew similarly to NEO’s over the last 12 months.

NEPH's P/E Growth Rating (100) in the null industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that NEPH’s stock grew similarly to NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEONEPH
RSI
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 11 days ago
75%
Declines
ODDS (%)
Bearish Trend 30 days ago
83%
Bearish Trend 7 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bullish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LEGN35.951.73
+5.06%
Legend Biotech Corp
ABT132.180.72
+0.55%
Abbott Laboratories
MTLS4.93-0.02
-0.40%
Materialise NV
AMPH29.39-1.42
-4.61%
Amphastar Pharmaceuticals
JUNS1.24-0.12
-8.82%
Jupiter Neurosciences Inc

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with RGEN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-7.04%
RGEN - NEO
38%
Loosely correlated
-3.74%
FLGT - NEO
37%
Loosely correlated
-1.30%
VCYT - NEO
36%
Loosely correlated
+1.69%
NNOX - NEO
36%
Loosely correlated
-0.79%
TWST - NEO
35%
Loosely correlated
-0.91%
More

NEPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with IMDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then IMDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
-1.19%
IMDX - NEPH
34%
Loosely correlated
-1.54%
SGHT - NEPH
33%
Loosely correlated
-1.81%
NEO - NEPH
25%
Poorly correlated
-7.04%
OFIX - NEPH
22%
Poorly correlated
-0.94%
VNRX - NEPH
22%
Poorly correlated
+0.27%
More